BRIEF-Omeros Corp announces positive data from OMS721 phase 2 trial By: Reuters: Company News October 20, 2016 at 10:28 AM EDT * Omeros announces positive data from OMS721 phase 2 trial in patients with stem cell transplant-associated thrombotic microangiopathy Read More >> Related Stocks: Omeros Corp